MFDS — authorised 24 November 2015
- Marketing authorisation holder: ELI LILLY CO
- Status: likely_approved
🇰🇷 Portrazza in South Korea
MFDS authorised Portrazza on 24 November 2015
Marketing authorisation
Portrazza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Portrazza approved in South Korea?
Yes. MFDS authorised it on 24 November 2015.
Who is the marketing authorisation holder for Portrazza in South Korea?
ELI LILLY CO holds the South Korean marketing authorisation.